California State Teachers Retirement System decreased its position in Azenta, Inc. (NASDAQ:AZTA – Free Report) by 11.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 41,506 shares of the company’s stock after selling 5,299 shares during the period. California State Teachers Retirement System owned 0.09% of Azenta worth $2,075,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. KBC Group NV lifted its position in Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company’s stock valued at $107,000 after purchasing an additional 698 shares during the period. State of Alaska Department of Revenue raised its stake in shares of Azenta by 355.2% during the fourth quarter. State of Alaska Department of Revenue now owns 25,899 shares of the company’s stock worth $1,294,000 after buying an additional 20,210 shares during the last quarter. Empowered Funds LLC acquired a new position in Azenta in the fourth quarter valued at approximately $293,000. Entropy Technologies LP boosted its stake in Azenta by 19.1% in the fourth quarter. Entropy Technologies LP now owns 15,581 shares of the company’s stock valued at $779,000 after acquiring an additional 2,496 shares during the last quarter. Finally, Stephens Inc. AR acquired a new stake in Azenta during the 4th quarter worth $313,000. Institutional investors own 99.08% of the company’s stock.
Azenta Stock Performance
AZTA opened at $28.75 on Friday. The firm’s fifty day moving average is $27.32 and its two-hundred day moving average is $39.86. The firm has a market cap of $1.32 billion, a PE ratio of -9.65 and a beta of 1.62. Azenta, Inc. has a twelve month low of $23.91 and a twelve month high of $63.58.
Analyst Ratings Changes
A number of research analysts have recently weighed in on AZTA shares. TD Cowen raised Azenta to a “hold” rating in a research note on Thursday, February 27th. Needham & Company LLC dropped their price objective on Azenta from $59.00 to $40.00 and set a “buy” rating for the company in a report on Wednesday, May 7th.
View Our Latest Stock Analysis on Azenta
Azenta Company Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Read More
- Five stocks we like better than Azenta
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- X: 1 Reason to Bet on U.S. Steel, and 1 Reason to Hold Back
- How to Calculate Stock Profit
- 3 Oversold Stocks Flashing Bullish Reversal Signals
- Health Care Stocks Explained: Why You Might Want to Invest
- With Novo Nordisk’s CEO Out, Wall Street Wants an American Leader
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.